French medical device firm EOS imaging has announced plans to launch its musculoskeletal imaging system, EOSedge, at RSNA Annual Meeting in Chicago, starting on 1 December.
The company has already received regulatory approvals to launch the product in Europe, Canada and Australia. However, it is yet to be approved by the US Food and Drug Administration (FDA).
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
EOSedge combines X-ray detection, low-dose radiation and high image resolution to deliver enhanced musculoskeletal imaging exams.
The product features Flex Dose technology to provide an optimised dose modulation and high image resolution photon-counting detection during musculoskeletal radiography.
The combination of optimised dose modulation and high image resolution will deliver optimal image quality in musculoskeletal imaging, the company claims.
The system also features an open cabin with a motorised patient platform, which facilitates access and positioning for patients.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataEOS imaging CEO Mike Lobinsky said: “We engineered EOSedge to equip both radiologists and orthopaedic surgeons with a best-in-class imaging system that combines the latest innovations to provide high-quality diagnostic capabilities of orthopaedic conditions at a low dose.
“Images and data obtained with EOSedge will further fuel our Advanced Orthopedic Solutions while addressing a broad range of imaging and orthopaedic surgery challenges. This breakthrough in orthopaedic imaging is the result of a multi-year development effort by our outstanding inter-disciplinary team.
“Unveiling EOSedge at RSNA, the largest global imaging convention, will mark another pivotal step in realising our strategic vision to deliver the best end-to-end solutions in orthopaedic care.”
Imagerie Médicale du Parc musculoskeletal radiologist Olivier Fantino said: “EOSedge is a leap forward in image quality, both in terms of spatial resolution and image contrast, all with a low radiation dose.
“Our months of utilisation in routine have also proven enhanced patient comfort, facilitated system operation and a strong reduction of exam time. We are thrilled with our experience of EOSedge and expect it to open up new fields of application use in musculoskeletal imaging.”
